Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7464872, 12 pages
https://doi.org/10.1155/2017/7464872
Research Article

Icariin Attenuates Synaptic and Cognitive Deficits in an Aβ1–42-Induced Rat Model of Alzheimer’s Disease

1Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
2Department of Integrated Traditional Chinese and Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China

Correspondence should be addressed to Chunhu Zhang; nc.ude.usc@77uhcz and Zhe Wang; nc.ude.usc@ehzgnawcire

Received 7 May 2017; Revised 31 July 2017; Accepted 14 August 2017; Published 19 September 2017

Academic Editor: Luigia Trabace

Copyright © 2017 Chenxia Sheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Wood, “Alzheimer disease: localized proteomics distinguishes AD subtypes,” Nature Reviews Neurology, vol. 13, article 260, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Sheng, W. Peng, Z. Chen et al., “Impact of 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-D-glucoside on cognitive deficits in animal models of Alzheimer's disease: a systematic review,” BMC Complementary and Alternative Medicine, vol. 16, article 320, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Mattsson, A. Lönneborg, M. Boccardi, K. Blennow, and O. Hansson, “Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework,” Neurobiology of Aging, vol. 52, pp. 196–213, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Arbel-Ornath, E. Hudry, J. R. Boivin et al., “Soluble oligomeric amyloid-beta induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain,” Molecular Neurodegeneration, vol. 12, article 27, 2017. View at Publisher · View at Google Scholar
  5. N. Geifman, R. D. Brinton, R. E. Kennedy, L. S. Schneider, and A. J. Butte, “Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease,” Alzheimer's Research and Therapy, vol. 9, article 10, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Wang, L. Xiong, W. Wan, L. Duan, X. Bai, and H. Zu, “Intranasal BMP9 ameliorates alzheimer disease-like pathology and cognitive deficits in APP/PS1 transgenic mice,” Frontiers in Molecular Neuroscience, vol. 10, article 32, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. Z.-Y. Zhang, C. Li, C. Zug, and H. J. Schluesener, “Icariin ameliorates neuropathological changes, TGF-β1 accumulation and behavioral deficits in a mouse model of cerebral amyloidosis,” PLoS ONE, vol. 9, no. 8, Article ID e104616, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Xia, W. Peng, S. Cheng et al., “Naoling decoction restores cognitive function by inhibiting the neuroinflammatory network in a rat model of Alzheimer’s disease,” Oncotarget, vol. 8, pp. 42648–42663, 2017. View at Publisher · View at Google Scholar
  9. D. Zhang, Z. Wang, C. Sheng et al., “Icariin prevents amyloid beta-induced apoptosis via the Pi3K/Akt pathway in PC-12 cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 235265, pp. 1–9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Chen, S. Han, X. Huang, J. Ni, and X. He, “The protective effect of icariin on mitochondrial transport and distribution in primary hippocampal neurons from 3x Tg-AD mice,” International Journal of Molecular Sciences, vol. 17, no. 2, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Chen and E. Schuman, “Circular RNAs in brain and other tissues: a functional enigma,” Trends in Neurosciences, vol. 39, no. 9, pp. 597–604, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Zhang, C. Shen, J. Chu, R. Zhang, Y. Li, and L. Li, “Icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer's disease,” International Journal of Biological Sciences, vol. 10, no. 2, pp. 181–191, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Jin, Q.-H. Gong, Y.-S. Xu et al., “Icariin, a phoshphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling,” International Journal of Neuropsychopharmacology, vol. 17, no. 6, pp. 871–881, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Chakroborty, J. Kim, C. Schneider, A. R. West, and G. E. Stutzmann, “Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer’s disease mice,” The Journal of Neuroscience, vol. 35, no. 17, pp. 6893–6902, 2015. View at Publisher · View at Google Scholar
  15. J.-H. Song, J.-T. Yu, and L. Tan, “Brain-derived neurotrophic factor in Alzheimer’s disease: risk, mechanisms, and therapy,” Molecular Neurobiology, vol. 52, no. 3, pp. 1477–1493, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Jerónimo-Santos, S. H. Vaz, S. Parreira et al., “Dysregulation of TrkB receptors and BDNF function by amyloid-β peptide is mediated by calpain,” Cerebral Cortex, vol. 25, no. 9, pp. 3107–3121, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Jimenez, M. Torres, M. Vizuete et al., “Age-dependent accumulation of soluble amyloid β (Aβ) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-α (sAPPα) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK- 3β pathway in Alzheimer mouse model,” Journal of Biological Chemistry, vol. 286, no. 21, pp. 18414–18425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Y.-S. Hu, N. Long, G. Pigino, S. T. Brady, and O. Lazarov, “Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling,” PLoS ONE, vol. 8, no. 5, Article ID e64460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Liu, X. Xue, H. Shi, L. Qi, and D. Gong, “Osthole upregulates bdnf to enhance adult hippocampal neurogenesis in APP/PS1 transgenic mice,” Biological & Pharmaceutical Bulletin, vol. 38, no. 10, pp. 1439–1449, 2015. View at Publisher · View at Google Scholar
  20. T. Nakai, T. Nagai, M. Tanaka et al., “Girdin phosphorylation is crucial for synaptic plasticity and memory: a potential role in the interaction of BDNF/TrkB/ Akt signaling with NMDA receptor,” Journal of Neuroscience, vol. 34, no. 45, pp. 14995–15008, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Wang, L. Yu, H. Yang et al., “Oridonin attenuates synaptic loss and cognitive deficits in an Aβ1-42-induced mouse model of Alzheimer's disease,” PLoS ONE, vol. 11, no. 3, Article ID e0151397, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. B. A. Chromy, R. J. Nowak, M. P. Lambert et al., “Self-assembly of Aβ1-42 into globular neurotoxins,” Biochemistry, vol. 42, no. 44, pp. 12749–12760, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Morroni, G. Sita, A. Tarozzi, R. Rimondini, and P. Hrelia, “Early effects of Aβ1-42 oligomers injection in mice: involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways,” Behavioural Brain Research, vol. 314, pp. 106–115, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Nie, Y. Luo, X.-N. Huang, Q.-H. Gong, Q. Wu, and J.-S. Shi, “Icariin inhibits beta-amyloid peptide segment 25–35 induced expression of beta-secretase in rat hippocampus,” European Journal of Pharmacology, vol. 626, no. 2-3, pp. 213–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Yang, Z.-A. Xia, B. Zhong et al., “Distinct hippocampal expression profiles of long non-coding RNAs in an Alzheimer’s disease model,” Molecular Neurobiology, pp. 1–14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. H.-B. Luo, Y. Li, Z.-J. Liu et al., “Protective effect of tetrahydroxy stilbene glucoside on learning and memory by regulating synaptic plasticity,” Neural Regeneration Research, vol. 11, no. 9, pp. 1480–1486, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. N. L. Alonso, S. P. Merino, S. Gonzalez, and J. Defelipe, “Synaptic changes in the dentate gyrus of APP/PS1 transgenic mice revealed by electron microscopy,” Journal of Neuropathology and Experimental Neurology, vol. 72, no. 5, pp. 386–395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Yang, S. Li, H. Xu, D. M. Walsh, and D. J. Selkoe, “Large soluble oligomers of amyloid β-protein from alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate,” Journal of Neuroscience, vol. 37, no. 1, pp. 152–163, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. B. L. Sinnen, A. B. Bowen, E. S. Gibson, and M. J. Kennedy, “Local and use-dependent effects of β-Amyloid oligomers on NMDA receptor function revealed by optical quantal analysis,” Journal of Neuroscience, vol. 36, no. 45, pp. 11532–11543, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Knoblauch, E. Körner, U. Körner, and F. T. Sommer, “Structural synaptic plasticity has high memory capacity and can explain graded amnesia, catastrophic forgetting, and the spacing effect,” PLoS ONE, vol. 9, no. 5, Article ID e96485, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Klevanski, U. Herrmann, S. W. Weyer et al., “The APP intracellular domain is required for normal synaptic morphology, synaptic plasticity, and hippocampus-dependent behavior,” Journal of Neuroscience, vol. 35, no. 49, pp. 16018–16033, 2015. View at Publisher · View at Google Scholar
  32. L. Zhou, Y. Hou, Q. Yang et al., “Tetrahydroxystilbene glucoside improves the learning and memory of amyloid-β1-42-injected rats and may be connected to synaptic changes in the hippocampus,” Canadian Journal of Physiology and Pharmacology, vol. 90, no. 11, pp. 1446–1455, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. C. B. Mantilla, J. M. Stowe, D. C. Sieck et al., “TrkB kinase activity maintains synaptic function and structural integrity at adult neuromuscular junctions,” Journal of Applied Physiology, vol. 117, no. 8, pp. 910–920, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Psotta, V. Lessmann, and T. Endres, “Impaired fear extinction learning in adult heterozygous BDNF knock-out mice,” Neurobiology of Learning and Memory, vol. 103, pp. 34–38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Endres and V. Lessmann, “Age-dependent deficits in fear learning in heterozygous BDNF knock-out mice,” Learning and Memory, vol. 19, no. 12, pp. 561–570, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. E. M. Borba, J. A. Duarte, G. Bristot, E. Scotton, A. L. Camozzato, and M. L. F. Chaves, “Brain-derived neurotrophic factor serum levels and hippocampal volume in mild cognitive impairment and dementia due to Alzheimer disease,” Dementia and Geriatric Cognitive Disorders Extra, vol. 6, no. 3, pp. 559–567, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Álvarez, M. Aleixandre, C. Linares, E. Masliah, and H. Moessler, “Apathy and APOE4 are associated with reduced BDNF levels in alzheimer's disease,” Journal of Alzheimer's Disease, vol. 42, no. 4, pp. 1347–1355, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Chadwick, N. Mitchell, J. Caroll et al., “Amitriptyline-mediated cognitive enhancement in aged 3 × Tg Alzheimer's disease mice is associated with neurogenesis and neurotrophic activity,” PLoS ONE, vol. 6, no. 6, Article ID e21660, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. C. Harward, N. G. Hedrick, C. E. Hall et al., “Autocrine BDNF-TrkB signalling within a single dendritic spine,” Nature, vol. 538, no. 7623, pp. 99–103, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Leal, D. Comprido, and C. B. Duarte, “BDNF-induced local protein synthesis and synaptic plasticity,” Neuropharmacology, vol. 76, part C, pp. 639–656, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Li, Q.-H. Gong, Q. Wu, Y.-F. Lu, and J.-S. Shi, “Icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in rats,” Pharmacology Biochemistry and Behavior, vol. 96, no. 3, pp. 301–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M.-J. Gong, B. Han, S.-M. Wang, S.-W. Liang, and Z.-J. Zou, “Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network disturbances revealed by NMR-based metabonomics in rats,” Journal of Pharmaceutical and Biomedical Analysis, vol. 123, pp. 63–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Carvalho, M. S. Santos, C. R. Oliveira, and P. I. Moreira, “Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers,” Biochimica et Biophysica Acta, vol. 1852, no. 8, pp. 1665–1675, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Llorens-Martín, A. Fuster-Matanzo, C. M. Teixeira et al., “GSK-3β overexpression causes reversible alterations on postsynaptic densities and dendritic morphology of hippocampal granule neurons in vivo,” Molecular Psychiatry, vol. 18, no. 4, pp. 451–460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Chen, S. Ou, L. Zhou, H. Tang, J. Xu, and K. Guo, “Formononetin attenuates Aβ25-35-induced cytotoxicity in HT22 cells via PI3K/Akt signaling and non-amyloidogenic cleavage of APP,” Neuroscience Letters, vol. 639, pp. 36–42, 2017. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Wu, X. Feng, T. Li, B. Sun, M. Z. Khan, and L. He, “Risperidone ameliorated Aβ1-42-induced cognitive and hippocampal synaptic impairments in mice,” Behavioural Brain Research, vol. 322, pp. 145–156, 2017. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Ghasemi, M. Moosavi, A. Zarifkar, K. Rastegar, and N. maghsoudi, “The interplay of Akt and ERK in Aβ toxicity and insulin-mediated protection in primary hippocampal cell culture,” Journal of Molecular Neuroscience, vol. 57, no. 3, pp. 325–334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Rickle, N. Bogdanovic, I. Volkman, B. Winblad, R. Ravid, and R. F. Cowburn, “Akt activity in Alzheimer's disease and other neurodegenerative disorders,” NeuroReport, vol. 15, no. 6, pp. 955–959, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. W.-X. Li, Y.-Y. Deng, F. Li et al., “Icariin, a major constituent of flavonoids from Epimedium brevicornum, protects against cognitive deficits induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats,” Pharmacology Biochemistry and Behavior, vol. 138, pp. 40–48, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Caraci, G. Battaglia, C. Busceti et al., “TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway,” Neurobiology of Disease, vol. 30, no. 2, pp. 234–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. W. Li, Q.-Z. He, C.-Q. Wu et al., “PFOS disturbs BDNF-ERK-CREB signalling in association with increased MicroRNA-22 in SH-SY5Y cells,” BioMed Research International, vol. 2015, Article ID 302653, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus